论文部分内容阅读
目的探讨放射治疗Ⅰ期子宫内膜癌术后患者的生存状况和预后的影响。方法选取2010年1月至2011年1月间进行术后放疗的164例Ⅰ期子宫内膜癌患者,采用门诊随访的形式对患者随访,对随访结果进行分析。结果 1、2、3、4和5年生存率分别为94.5%、91.5%、87.8%、82.3%和76.8%,中位生存时间为54个月。年龄、放疗前贫血、子宫下段受累和内分泌治疗对患者的生存期有影响(均P<0.05)。年龄、放疗前贫血、子宫下段受累和内分泌治疗是预后的独立影响因素(均P<0.05)。结论Ⅰ期子宫内膜癌患者手术后放射治疗的5年生存率高,年龄、放疗前贫血、子宫下段受累和内分泌治疗是预后的独立影响因素。
Objective To investigate the effect of radiotherapy on the survival and prognosis of postoperative patients with stage Ⅰ endometrial cancer. Methods A total of 164 patients with stage Ⅰ endometrial cancer undergoing postoperative radiotherapy between January 2010 and January 2011 were selected and followed up for follow-up. The follow-up results were analyzed. Results The 1, 2, 3, 4 and 5-year survival rates were 94.5%, 91.5%, 87.8%, 82.3% and 76.8%, respectively. The median survival time was 54 months. Age, pre-radiotherapy anemia, involvement of the lower uterine segment and endocrine therapy had an impact on the survival of patients (all P <0.05). Age, pre-radiotherapy anemia, uterine involvement and endocrine therapy were independent prognostic factors (all P <0.05). Conclusions The 5-year survival rate of patients with stage I endometrial cancer after radiotherapy is high. Age, pre-radiotherapy anemia, uterine segment involvement and endocrine therapy are independent prognostic factors.